Via Digitalcongo.net, an August 23 AFP report: Although hastily equated with Ebola hemorrhagic fever reported the alarming Equateur still casts doubt of WHO and MSF. Excerpt from the Google translation:
The World Health Organization (WHO) and Doctors Without Borders (MSF) are still reluctant to comment on the true nature of the sudden outbreak of hemorrhagic fever emerged in the Congolese province of Equateur and causing numerous mysterious deaths while rumors were not substantiated by reliable medical tests support the view of a new outbreak of Ebola fear as is the sad case in West Africa.
With the dead in series of Ecuador, the World Health Organization (WHO) and the NGO Doctors Without Borders abstained prematurely to any connection with the Ebola virus, it is too early to say that it is a hemorrhagic fever, which causes the death of 13 people in the northwest of the Democratic Republic of Congo, warned yesterday the WHO and MSF.
"Many died with bleeding symptoms, but there are severe malaria that can also give these symptoms, or typhoid fever, " he told AFP on condition of anonymity, an official of the World Health Organization based in Kinshasa.
"We are still waiting biological confirmations to determine what kind of disease it is," said AFP's communications officer for MSF in Kinshasa, Amanda Cohn, whose teams are present in the affected area, Boende, a territory of the Province of Equateur (Northwest).
Minister of Public Health, Dr. Felix Kabange Numbi said Thursday AFP that "13 people have died since August he hemorrhagic fever of unknown origin", stressing that they presented, "terminally ill, vomiting of blackish material."
The first victim of hemorrhagic fever was a pregnant woman and the other twelve people died after being in contact with during his illness and after her death.
"Five health personnel have died, year doctor, two nurses, a medical officer and a waiter. The other victims were relatives or the villagers who attended the funeral," said the minister, adding that since protection kits have been distributed to health personnel.
Samples were carried out and must be treated at the National Institute of Biomedical Research (INRB) and the laboratory in Franceville, Gabon, to determine the exact origin of the disease.